Brind.

Silence Therapeutics is listed on the Nasdaq stock exchange.

1 report, 1 independent Updated Aug 4

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Silence Therapeutics Nasdaq

Keep exploring

The entities involved

Silence Therapeutics
UK business
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.Wed 20:36
Nasdaq
American fully electronic stock exchange
- Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
- Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.Sep 22
HCW Biologics announced it is listed on the Nasdaq stock exchange.Thu 14:07
Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.Aug 18
Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.Wed 10:43

Coverage

Newest first; wire copies grouped

Aug 4tickerreport.com